AbbVie Revenue Rises on Strength in Immunology, Neuroscience
AbbVie reports Q3 2026 sales performance aligned with analyst estimates, driven by growth in its immunology and neuroscience portfolios.
37 trends tracked about this subject — the full history, oldest to newest below.
AbbVie reports Q3 2026 sales performance aligned with analyst estimates, driven by growth in its immunology and neuroscience portfolios.
New studies show rare and common DNA variants jointly steer immune cell activity, tightening the link between genetics and disease.
Medical reports reveal that specific antibody signatures could predict inflammatory bowel disease a decade prior to formal diagnosis.
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent scientific studies and medical reports examine a preinvasive regulatory T cell axis and immune fog for lung cancer interception.
Science coverage details how phage proteases activate CBASS antiphage immunity.
Sanofi and Regeneron have deepened their immunology alliance in a deal worth up to $8 billion to secure early-stage assets and a Dupixent successor.
New research reveals how specific stomach bacteria hijack immune healing signals to drive the development of precancerous changes in the gastric lining.
Researchers from SKKU have identified T-cells and bone marrow disruptions as external drivers of Alzheimer's, suggesting new ways to limit neurodegeneration.
9 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Immunology drugmaker Electra Therapeutics pursues an upsized $350 million initial public offering on Nasdaq under the ticker ETRA.
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
New research reveals how chronic type II interferon can inadvertently promote tumor growth via mitochondrial RNA and prostaglandin synthesis.
Recent scientific coverage details how tumor-derived antioxidants suppress immunity by depriving T cells of reactive oxygen species.
New scientific evidence from AAAS reveals potential mechanisms through which destructive immune cells cause damage within the human brain.
Researchers have identified a single immune signal that acts as an aging switch, which, when blocked, restored youthful behavior in older mice.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Eli Lilly is expanding its autoimmune portfolio through the acquisition of Merida Biosciences in a deal valued at up to $2.875 billion.
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Deerfield-backed startup Boulevard Bio launches with $65M and a trio of immunology drugs targeting autoimmune cures.
8 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent scientific research explores how human lung immune cells protect against infections and potentially drive autoimmune disease.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
10 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Advancements in mRNA technology have brought the development of an HIV vaccine closer to reality through new neutralizing antibody responses.
USC scientists have engineered a technique to produce an unlimited supply of cancer-fighting immune cells.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Mayo Clinic researchers have challenged decades of scientific understanding regarding the MHC I molecule and its role in the immune system's fight against cancer.
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
AbbVie has announced a $10.9 billion acquisition of Apogee Therapeutics to expand its immunology drug portfolio.
Research indicates that Denisovan genetic material continues to impact the immune responses of individuals in the South Pacific.
13 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
12 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.